1.
Product Overview
2.
Research Methodology
3.
Impact of COVID-19 on Global Transgenic Animal Market
4.
Executive Summary
5.
Voice of Customer
6.
Clinical Trial Analysis
7. Global Transgenic
Animal Market Outlook
7.1.
Market Size & Forecast
7.1.1. By Value
7.2.
Market Share & Forecast
7.2.1. By Product (Gene Gun, PCR, Microinjections, Others)
7.2.1.1.
By PCR (Real-Time PCR, Digital
PCR Systems, Others)
7.2.2. By Technique (DNA Microinjection, Embryonic Stem Cell-Mediated Gene
Transfer, Retrovirus-Mediated Gene Transfer and Others)
7.2.3. By Application (Recombinant Human Proteins, Monoclonal Antibodies, Xenotransplantation,
Others)
7.2.4. By Model Organisms (Mice, Rabbit, Cow, Others)
7.2.5. By End User (Biotechnology & Pharmaceutical Companies, Academic
& Research Organizations, Others)
7.2.6. By Company (2021)
7.2.7. By Region
7.3.
Product Market Map
8. North America Transgenic
Animal Market Outlook
8.1.
Market Size & Forecast
8.1.1. By Value
8.2.
Market Share & Forecast
8.2.1. By Product (Gene Gun, PCR, Microinjections, Others)
8.2.1.1.
By PCR (Real-Time PCR, Digital
PCR Systems, Others)
8.2.2. By Technique (DNA Microinjection, Embryonic Stem Cell-Mediated Gene
Transfer, Retrovirus-Mediated Gene Transfer and Others)
8.2.3. By Application (Recombinant Human Proteins, Monoclonal Antibodies, Xenotransplantation,
Others)
8.2.4. By Model Organisms (Mice, Rabbit, Cow, Others)
8.2.5. By End User (Biotechnology & Pharmaceutical Companies, Academic
& Research Organizations, Others)
8.2.6. By Country
8.3.
North America: Country Analysis
8.3.1. United States Transgenic
Animal Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Product
8.3.1.2.2.
By Technique
8.3.1.2.3.
By Application
8.3.1.2.4.
By Model Organisms
8.3.1.2.5.
By End User
8.3.2. Mexico Transgenic
Animal Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Product
8.3.2.2.2.
By Technique
8.3.2.2.3.
By Application
8.3.2.2.4.
By Model Organisms
8.3.2.2.5.
By End User
8.3.3. Canada Transgenic
Animal Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Product
8.3.3.2.2.
By Technique
8.3.3.2.3.
By Application
8.3.3.2.4.
By Model Organisms
8.3.3.2.5.
By End User
9. Europe Transgenic
Animal Market Outlook
9.1.
Market Size & Forecast
9.1.1. By Value
9.2.
Market Share & Forecast
9.2.1. By Product (Gene Gun, PCR, Microinjections, Others)
9.2.1.1.
By PCR (Real-Time PCR, Digital
PCR Systems, Others)
9.2.2. By Technique (DNA Microinjection, Embryonic Stem Cell-Mediated Gene
Transfer, Retrovirus-Mediated Gene Transfer and Others)
9.2.3. By Application (Recombinant Human Proteins, Monoclonal Antibodies, Xenotransplantation,
Others)
9.2.4. By Model Organisms (Mice, Rabbit, Cow, Others)
9.2.5. By End User (Biotechnology & Pharmaceutical Companies, Academic
& Research Organizations, Others)
9.2.6. By Country
9.3.
Europe: Country Analysis
9.3.1. France Transgenic
Animal Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Product
9.3.1.2.2.
By Technique
9.3.1.2.3.
By Application
9.3.1.2.4.
By Model Organisms
9.3.1.2.5.
By End User
9.3.2. Germany Transgenic
Animal Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Product
9.3.2.2.2.
By Technique
9.3.2.2.3.
By Application
9.3.2.2.4.
By Model Organisms
9.3.2.2.5.
By End User
9.3.3. United Kingdom Transgenic
Animal Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Product
9.3.3.2.2.
By Technique
9.3.3.2.3.
By Application
9.3.3.2.4.
By Model Organisms
9.3.3.2.5.
By End User
9.3.4. Italy Transgenic
Animal Market Outlook
9.3.4.1.
Market Size & Forecast
9.3.4.1.1.
By Value
9.3.4.2.
Market Share & Forecast
9.3.4.2.1.
By Product
9.3.4.2.2.
By Technique
9.3.4.2.3.
By Application
9.3.4.2.4.
By Model Organisms
9.3.4.2.5.
By End User
9.3.5. Spain Transgenic
Animal Market Outlook
9.3.5.1.
Market Size & Forecast
9.3.5.1.1.
By Value
9.3.5.2.
Market Share & Forecast
9.3.5.2.1.
By Product
9.3.5.2.2.
By Technique
9.3.5.2.3.
By Application
9.3.5.2.4.
By Model Organisms
9.3.5.2.5.
By End User
10. Asia-Pacific Transgenic
Animal Market Outlook
10.1.
Market Size & Forecast
10.1.1. By Value
10.2.
Market Share & Forecast
10.2.1. By Product (Gene Gun, PCR, Microinjections, Others)
10.2.1.1. By PCR (Real-Time PCR, Digital PCR Systems, Others)
10.2.2. By Technique (DNA Microinjection, Embryonic Stem Cell-Mediated Gene
Transfer, Retrovirus-Mediated Gene Transfer and Others)
10.2.3. By Application (Recombinant Human Proteins, Monoclonal Antibodies, Xenotransplantation,
Others)
10.2.4. By Model Organisms (Mice, Rabbit, Cow, Others)
10.2.5. By End User (Biotechnology & Pharmaceutical Companies, Academic
& Research Organizations, Others)
10.2.6. By Country
10.3.
Asia-Pacific: Country Analysis
10.3.1. China Transgenic
Animal Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1.
By Product
10.3.1.2.2.
By Technique
10.3.1.2.3.
By Application
10.3.1.2.4.
By Model Organisms
10.3.1.2.5.
By End User
10.3.2. India Transgenic
Animal Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1.
By Product
10.3.2.2.2.
By Technique
10.3.2.2.3.
By Application
10.3.2.2.4.
By Model Organisms
10.3.2.2.5.
By End User
10.3.3. Japan Transgenic
Animal Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1.
By Product
10.3.3.2.2.
By Technique
10.3.3.2.3.
By Application
10.3.3.2.4.
By Model Organisms
10.3.3.2.5.
By End User
10.3.4. South Korea Transgenic
Animal Market Outlook
10.3.4.1. Market Size & Forecast
10.3.4.1.1.
By Value
10.3.4.2. Market Share & Forecast
10.3.4.2.1.
By Product
10.3.4.2.2.
By Technique
10.3.4.2.3.
By Application
10.3.4.2.4.
By Model Organisms
10.3.4.2.5.
By End User
10.3.5. Australia Transgenic
Animal Market Outlook
10.3.5.1. Market Size & Forecast
10.3.5.1.1.
By Value
10.3.5.2. Market Share & Forecast
10.3.5.2.1.
By Product
10.3.5.2.2.
By Technique
10.3.5.2.3.
By Application
10.3.5.2.4.
By Model Organisms
10.3.5.2.5.
By End User
10.3.6. Vietnam Transgenic
Animal Market Outlook
10.3.6.1. Market Size & Forecast
10.3.6.1.1.
By Value
10.3.6.2. Market Share & Forecast
10.3.6.2.1.
By Product
10.3.6.2.2.
By Technique
10.3.6.2.3.
By Application
10.3.6.2.4.
By Model Organisms
10.3.6.2.5.
By End User
10.3.7. Indonesia Transgenic
Animal Market Outlook
10.3.7.1. Market Size & Forecast
10.3.7.1.1.
By Value
10.3.7.2. Market Share & Forecast
10.3.7.2.1.
By Product
10.3.7.2.2.
By Technique
10.3.7.2.3.
By Application
10.3.7.2.4.
By Model Organisms
10.3.7.2.5.
By End User
10.3.8. Singapore Transgenic
Animal Market Outlook
10.3.8.1. Market Size & Forecast
10.3.8.1.1.
By Value
10.3.8.2. Market Share & Forecast
10.3.8.2.1.
By Product
10.3.8.2.2.
By Technique
10.3.8.2.3.
By Application
10.3.8.2.4.
By Model Organisms
10.3.8.2.5.
By End User
11. South America Transgenic
Animal Market Outlook
11.1.
Market Size & Forecast
11.1.1. By Value
11.2.
Market Share & Forecast
11.2.1. By Product (Gene Gun, PCR, Microinjections, Others)
11.2.1.1. By PCR (Real-Time PCR, Digital PCR Systems, Others)
11.2.2. By Technique (DNA Microinjection, Embryonic Stem Cell-Mediated Gene
Transfer, Retrovirus-Mediated Gene Transfer and Others)
11.2.3. By Application (Recombinant Human Proteins, Monoclonal Antibodies, Xenotransplantation,
Others)
11.2.4. By Model Organisms (Mice, Rabbit, Cow, Others)
11.2.5. By End User (Biotechnology & Pharmaceutical Companies, Academic
& Research Organizations, Others)
11.2.6. By Country
11.3.
South America: Country Analysis
11.3.1. Brazil Transgenic
Animal Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1.
By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1.
By Product
11.3.1.2.2.
By Technique
11.3.1.2.3.
By Application
11.3.1.2.4.
By Model Organisms
11.3.1.2.5.
By End User
11.3.2. Argentina Transgenic
Animal Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1.
By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1.
By Product
11.3.2.2.2.
By Technique
11.3.2.2.3.
By Application
11.3.2.2.4.
By Model Organisms
11.3.2.2.5.
By End User
11.3.3. Colombia Transgenic
Animal Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1.
By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1.
By Product
11.3.3.2.2.
By Technique
11.3.3.2.3.
By Application
11.3.3.2.4.
By Model Organisms
11.3.3.2.5.
By End User
11.3.4. Chile Transgenic
Animal Market Outlook
11.3.4.1. Market Size & Forecast
11.3.4.1.1.
By Value
11.3.4.2. Market Share & Forecast
11.3.4.2.1.
By Product
11.3.4.2.2.
By Technique
11.3.4.2.3.
By Application
11.3.4.2.4.
By Model Organisms
11.3.4.2.5.
By End User
12. Middle East and
Africa Transgenic Animal Market Outlook
12.1.
Market Size & Forecast
12.1.1. By Value
12.2.
Market Share & Forecast
12.2.1. By Product (Gene Gun, PCR, Microinjections, Others)
12.2.1.1. By PCR (Real-Time PCR, Digital PCR Systems, Others)
12.2.2. By Technique (DNA Microinjection, Embryonic Stem Cell-Mediated Gene
Transfer, Retrovirus-Mediated Gene Transfer and Others)
12.2.3. By Application (Recombinant Human Proteins, Monoclonal Antibodies, Xenotransplantation,
Others)
12.2.4. By Model Organisms (Mice, Rabbit, Cow, Others)
12.2.5. By End User (Biotechnology & Pharmaceutical Companies, Academic
& Research Organizations, Others)
12.2.6. By Country
12.3.
MEA: Country Analysis
12.3.1. South Africa Transgenic
Animal Market Outlook
12.3.1.1. Market Size & Forecast
12.3.1.1.1.
By Value
12.3.1.2. Market Share & Forecast
12.3.1.2.1.
By Product
12.3.1.2.2.
By Technique
12.3.1.2.3.
By Application
12.3.1.2.4.
By Model Organisms
12.3.1.2.5.
By End User
12.3.2. Saudi Arabia Transgenic
Animal Market Outlook
12.3.2.1. Market Size & Forecast
12.3.2.1.1.
By Value
12.3.2.2. Market Share & Forecast
12.3.2.2.1.
By Product
12.3.2.2.2.
By Technique
12.3.2.2.3.
By Application
12.3.2.2.4.
By Model Organisms
12.3.2.2.5.
By End User
12.3.3. UAE Transgenic
Animal Market Outlook
12.3.3.1. Market Size & Forecast
12.3.3.1.1.
By Value
12.3.3.2. Market Share & Forecast
12.3.3.2.1.
By Product
12.3.3.2.2.
By Technique
12.3.3.2.3.
By Application
12.3.3.2.4.
By Model Organisms
12.3.3.2.5.
By End User
12.3.4. Egypt Transgenic
Animal Market Outlook
12.3.4.1. Market Size & Forecast
12.3.4.1.1.
By Value
12.3.4.2. Market Share & Forecast
12.3.4.2.1.
By Product
12.3.4.2.2.
By Technique
12.3.4.2.3.
By Application
12.3.4.2.4.
By Model Organisms
12.3.4.2.5.
By End User
12.3.5. Turkey Transgenic
Animal Market Outlook
12.3.5.1. Market Size & Forecast
12.3.5.1.1.
By Value
12.3.5.2. Market Share & Forecast
12.3.5.2.1.
By Product
12.3.5.2.2.
By Technique
12.3.5.2.3.
By Application
12.3.5.2.4.
By Model Organisms
12.3.5.2.5.
By End User
13.
Market Dynamics
13.1.
Drivers
13.2.
Challenges
14.
Market Trends & Developments
15.
Competitive Landscape (inclusive of SWOT Analysis)
15.1.
Merck & Co., Inc.
15.2.
C.H. Boehringer Sohn Ko. KG
15.3.
Randox Laboratories Limited
15.4.
Zoetis, Inc.
15.5.
Virbac SA
15.6.
Elanco Animal Health Inc.
15.7.
Biogénesis Bagó SA
15.8.
Santa Cruz Biotechnology, Inc
15.9.
Idexx Laboratories, Inc.
15.10.
Innovative Diagnostics (IDVet)
16. Strategic Recommendations